Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AptarGroupFRA:AGT +0.45%79 Market Cap is €7,552 Mil as of Jul. 17, 2026. GuruFocus rates FRA:AGT with a GF Score™ of 79/100 and a GF Value™ of €129.97 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 866 Medical Devices & Instruments companies, AptarGroup ranks better than 95.15% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). AptarGroup's share price for the quarter that ended in Mar. 2026 was €106.4. AptarGroup's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 64 Mil. Therefore, AptarGroup's market cap for the quarter that ended in Mar. 2026 was €6,799 Mil.
AptarGroup's quarterly market cap
declined
from Sep. 2025 (€7,371 Mil) to Dec. 2025 (€6,704 Mil) but then
increased
from Dec. 2025 (€6,704 Mil) to Mar. 2026 (€6,799 Mil).
AptarGroup's annual market cap
increased
from Dec. 2023 (€7,414 Mil) to Dec. 2024 (€10,048 Mil) but then
declined
from Dec. 2024 (€10,048 Mil) to Dec. 2025 (€6,704 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. AptarGroup's Enterprise Value for Today is €8,627 Mil.
AptarGroup (FRA:AGT) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
AptarGroup Market Cap Related Terms
AptarGroup Market Cap Historical Data
* Premium members only.
The historical data trend for AptarGroup's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, AptarGroup's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AptarGroup Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AptarGroup's Market Cap distribution charts can be found below:
* The bar in red indicates where AptarGroup's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
AptarGroup's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AptarGroup (FRA:AGT) has a Market Cap of €7,552 Mil as of Jul. 17, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on AptarGroup and its competitors. According to the industry distribution chart, AptarGroup ranks #42 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 4.8%.
Is AptarGroup's Market Cap too high?
AptarGroup's current Market Cap is €7,552 Mil. Based on the distribution chart, AptarGroup ranks #42 out of 866 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, AptarGroup has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does AptarGroup's Market Cap compare to RGEN and AVTR?
According to the Medical Devices & Instruments industry distribution chart, AptarGroup ranks #42 out of 866 companies for Market Cap. This places AptarGroup in the top 5% of its industry — outperforming the majority of peers. The industry median Market Cap is 115.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 115.63, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on AptarGroup and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 115.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AptarGroup's current Market Cap is €7,552 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AptarGroup stock overvalued right now?
Based on GuruFocus' analysis, AptarGroup (FRA:AGT) is currently considered Modestly Undervalued. The stock's GF Value™ is €129.97, compared to a current price of €111.20 — trading 14.4% below its estimated fair value. The current Market Cap is €7,552 Mil. AptarGroup's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For AptarGroup (FRA:AGT), the current Market Cap is €7,552 Mil as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AptarGroup (FRA:AGT) Overvalued in 2026?
Based on GuruFocus' analysis, AptarGroup stock appears to be undervalued.
The current stock price of €111.20 is trading 14.4% below its estimated GF Value™ of €129.97.
GuruFocus considers AptarGroup to be Modestly Undervalued.
Key valuation signals for FRA:AGT:
Market Cap: €7,552 Mil
GF Value™: €129.97 vs. price of €111.20 (14.4% below fair value)
No single metric tells the full story. See the FRA:AGT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. Its sales are primarily from Europe (49% of sales) and the United States (28%), with China contributing 5% and other countries contributing 17%. It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.
79GF Score
Get the complete analysis for FRA:AGT
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:AGT has been successfully added to your 
